Published March 24, 2022
| Version v1.3
Other
Open
SDHB/D: CanVIG-UK Gene-Specific Guidance
Authors/Creators
- 1. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
- 2. Sheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust
- 3. East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
- 4. Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University Hospitals NHS Foundation Trust, Manchester, UK
- 5. Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK
- 6. Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK
- 7. Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton, UK
- 8. University of Cambridge, Cambridge, UK
- 9. St George's University Hospitals NHS Foundation Trust, Tooting, London, UK
- 10. The Royal Marsden NHS Foundation Trust, Fulham Road, London, UK
Description
For use in conjunction with CanVIG-UK Consensus Specification for Cancer susceptibility Genes of ACGS Best Practice Guidelines for Variant Classification. Evidence lines for which there are no gene-specific recommendations should be reviewed in context of CanVIG-UK Consensus Specification for Cancer Susceptibility Genes.